Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VPHM - Viropharma Inc -- Ignore unavailable to you. Want to Upgrade?

To: Ron who wrote (287)	9/3/1999 10:05:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2557

>> Indeed, but the short term resistance is clearly 7 1/2. Be happy with 10 in less than a week. Good luck to all. << You didn't make it. When I look at the chart, I see short-term resistance at 21. Different perspective. You could try to make an informed decision about near-term targets by contacting IR about upcoming presentations and by looking at the estimated size of the market for viral meningitis? Thread....... true to their pharma roots.... I contacted IR about news regarding the RSV and HCV projects. Both INDs are expected within 6 months, but no information will be presented regarding either project until ViroPharma has clinical data to report.